tiprankstipranks
Trending News
More News >
Protagenic Therapeutics (PTIX)
NASDAQ:PTIX
US Market

Protagenic Therapeutics (PTIX) Cash flow

Compare
91 Followers

Protagenic Therapeutics Cash Flow

PTIX's free cash flow for Q3 2025 was $-1.49M. For the 2025 fiscal year, PTIX's free cash flow was decreased by $-362.97K and operating cash flow was $-1.49M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -4.22M$ -3.70M$ -1.99M$ -2.80M$ -1.35M
Investing Cash Flow
$ 2.80M$ 4.78M$ 1.60M$ -9.91M$ 0.00
Financing Cash Flow
$ 1.96M$ 0.00$ 0.00$ 12.58M$ 1.22M
End Cash Position
$ 1.84M$ 1.29M$ 215.19K$ 541.17K$ 671.09K
Free Cash Flow
$ -4.22M$ -3.85M$ -2.00M$ -2.80M$ -1.35M
Currency in USD

Protagenic Therapeutics Cash Flow